TBI-GENERAL COGNITIVE (PHARMACOLOGIC) MGM

From NeuroRehab.wiki

Revision as of 09:56, 25 July 2023 by Dr Appukutty Manickam (talk | contribs) (Imported from text file)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

SUMMARY

EFFECTIVE
1. Recombinant human Growth Hormone (rhGH) is superior to placebo at improving processing speed, executive function and learning in patients post TBI (level 1b).

INEFFECTIVE
1. The effectiveness of methylphenidate to improve cognitive impairment following brain injury is unclear.
2. Dextroamphetamine, sertraline, bromocriptine & amantadine are not effective.


Reference(s)

Marshall S, Harnett A, Welch-West P, Ferri C, Janzen S, Togher L, Teasell R. (2021). Rehabilitation of Problem Solving, Executive and General Cognitive Functioning Post Acquired Brain Injury. In Teasell R, Cullen N, Marshall S, Bayley M, Harnett A editors. Evidence-Based Review of Moderate to Severe Acquired Brain Injury. Version 14.0: p1-64.
Cifu, D.X. (2020). Braddom’s physical medicine and rehabilitation. Elsevier. Get it on Amazon.
Cuccurullo, S. (2019). Physical medicine and rehabilitation board review. New York: Demosmedical. Get it on Amazon.
O’Young, B., Young, M.A. and Stiens, S.A. (2008). Physical Medicine and Rehabilitation Secrets. Mosby. Get it on Amazon.

Retrieved from "https://www.neurorehab.wiki/index.php?title=TBI-GENERAL_COGNITIVE_(PHARMACOLOGIC)_MGM&oldid=20855"